In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Applied Dna Sciences Inc (NASDAQ: APDN) closed at $0.31 down -1.87% from its previous closing price of $0.32. In other words, the price has decreased by -$1.87 from its previous closing price. On the day, 2.58 million shares were traded. APDN stock price reached its highest trading level at $0.321 during the session, while it also had its lowest trading level at $0.2851.
Ratios:
For a deeper understanding of Applied Dna Sciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.76 and its Current Ratio is at 3.91. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH Capital on February 12, 2021, initiated with a Buy rating and assigned the stock a target price of $24.
On January 14, 2021, H.C. Wainwright reiterated its Buy rating and also upped its target price recommendation from $18 to $14.
H.C. Wainwright reiterated its Buy rating for the stock on December 18, 2020, while the target price for the stock was revised from $20 to $12.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APDN now has a Market Capitalization of 3244311 and an Enterprise Value of -6487275. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.95 while its Price-to-Book (P/B) ratio in mrq is 0.26. Its current Enterprise Value per Revenue stands at -1.909 whereas that against EBITDA is 0.464.
Stock Price History:
Over the past 52 weeks, APDN has reached a high of $22.80, while it has fallen to a 52-week low of $0.31. The 50-Day Moving Average of the stock is -70.50%, while the 200-Day Moving Average is calculated to be -93.78%.
Shares Statistics:
For the past three months, APDN has traded an average of 10.21M shares per day and 5114290 over the past ten days. A total of 10.30M shares are outstanding, with a floating share count of 10.29M. Insiders hold about 0.14% of the company’s shares, while institutions hold 13.91% stake in the company. Shares short for APDN as of 1727654400 were 1744293 with a Short Ratio of 0.17, compared to 1724976000 on 2143575. Therefore, it implies a Short% of Shares Outstanding of 1744293 and a Short% of Float of 16.96.
